These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3112467)

  • 21. Physicochemical characterization and transformation of the cytosolic glucocorticoid receptor from rabbit liver.
    Blanchardie P; Lustenberger P; Orsonneau JL; Bernard S
    J Steroid Biochem; 1983 Jun; 18(6):789-99. PubMed ID: 6865418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of molybdate on glucocorticoid receptor transformation and translocation in intact, viable AtT-20 mouse pituitary tumor cells.
    Svec F
    J Steroid Biochem; 1985 Oct; 23(4):529-33. PubMed ID: 4068714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo activation and nuclear binding of the AtT-20 mouse pituitary tumor cell glucocorticoid receptor.
    Miyabe S; Harrison RW
    Endocrinology; 1983 Jun; 112(6):2174-80. PubMed ID: 6851944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dynamic model of glucocorticoid receptor phosphorylation and cycling in intact cells.
    Ortí E; Mendel DB; Smith LI; Bodwell JE; Munck A
    J Steroid Biochem; 1989; 34(1-6):85-96. PubMed ID: 2626055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ontogony of the human placental glucocorticoid receptor and inducibility of heat-stable alkaline phosphatase.
    Speeg KV; Harrison RW
    Endocrinology; 1979 May; 104(5):1364-8. PubMed ID: 436782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation and changes in the sedimentation properties of rat liver glucocorticoid receptor.
    Alexis MN; Djordević-Marković R; Sekeris CE
    J Steroid Biochem; 1983 Jun; 18(6):655-63. PubMed ID: 6865409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the glucocorticoid antagonist action of dexamethasone 21-mesylate in HeLa S3 cells.
    Scheible PP; DeLorenzo TM; Cidlowski JA
    J Steroid Biochem; 1987 Feb; 26(2):181-7. PubMed ID: 3560935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the glucocorticoid-receptor complex.
    Schmidt TJ; Barnett CA; Litwack G
    J Cell Biochem; 1982; 20(1):15-27. PubMed ID: 6761347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that removal of an endogenous metal that stabilizes the untransformed glucocorticoid receptor in cytosol allows ligand-independent receptor transformation.
    Meshinchi S; Pratt WB
    J Steroid Biochem; 1989; 34(1-6):315-7. PubMed ID: 2626024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of calf intestinal alkaline phosphatase, phosphatase inhibitors, and phosphorylated compounds on the rate of activation of glucocorticoid-receptor complexes.
    Barnett CA; Schmidt TJ; Litwack G
    Biochemistry; 1980 Nov; 19(23):5446-55. PubMed ID: 7448180
    [No Abstract]   [Full Text] [Related]  

  • 31. RNA binding to the untransformed glucocorticoid receptor. Sensitivity to substrate-specific ribonucleases and characterization of a ribonucleic acid associated with the purified receptor.
    Sablonnière B; Economidis IV; Lefebvre P; Place M; Richard C; Formstecher P; Rousseau GG; Dautrevaux M
    Eur J Biochem; 1988 Nov; 177(2):371-82. PubMed ID: 2461303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between intact cell ATP levels and glucocorticoid receptor-binding capacity in the AtT-20 cell.
    Svec F
    Biochim Biophys Acta; 1985 Oct; 847(1):147-54. PubMed ID: 4052457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of detectable ribonucleic acid in the purified, untransformed mouse glucocorticoid receptor.
    Kovacic-Milivojević B; Vedeckis WV
    Biochemistry; 1986 Dec; 25(25):8266-73. PubMed ID: 3814582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of mammary cytoplasmic glucocorticoid receptor under cell-free conditions.
    McBlain WA; Toft DO; Shyamala G
    Biochemistry; 1981 Nov; 20(24):6790-8. PubMed ID: 7317353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-mediated inactivation and transformation of mammary cytoplasmic glucocorticoid receptor.
    McBlain WA; Shyamala G
    J Steroid Biochem; 1984 Jun; 20(6A):1211-20. PubMed ID: 6748637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutral cholesteryl ester hydrolase in the rat lactating mammary gland: regulation by phosphorylation-dephosphorylation.
    Martinez MJ; Botham KM
    Biochim Biophys Acta; 1990 Oct; 1047(1):90-8. PubMed ID: 2174266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors.
    Garte SJ; Currie DD; Troll W
    Cancer Res; 1987 Jun; 47(12):3159-62. PubMed ID: 3495328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human interleukin-1 inhibits the induction by dexamethasone of alkaline phosphatase activity in murine capillary endothelial cells.
    Mulkins MA; Allison AC
    J Cell Physiol; 1987 Dec; 133(3):539-45. PubMed ID: 3500955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid receptor cleavage by leupeptin-sensitive enzymes in rat kidney cytosol.
    Sherman MR; Barzilai D; Pine PR; Tuazon FB
    Adv Exp Med Biol; 1979; 117():357-75. PubMed ID: 474286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of transformed glucocorticoid receptor from dexamethasone resistant melanoma.
    Hutchens TW; Hawkins EF; Markland FS
    J Steroid Biochem; 1982 Jun; 16(6):705-11. PubMed ID: 7109574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.